89 related articles for article (PubMed ID: 29627026)
1. Ganciclovir and foscarnet dual-therapy for cytomegalovirus encephalitis: A case report and review of the literature.
Baghban A; Malinis M
J Neurol Sci; 2018 May; 388():28-36. PubMed ID: 29627026
[TBL] [Abstract][Full Text] [Related]
2. Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection.
Avery RK; Arav-Boger R; Marr KA; Kraus E; Shoham S; Lees L; Trollinger B; Shah P; Ambinder R; Neofytos D; Ostrander D; Forman M; Valsamakis A
Transplantation; 2016 Oct; 100(10):e74-80. PubMed ID: 27495775
[TBL] [Abstract][Full Text] [Related]
3. Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.
Ongrádi J; Ablashi DV; Yoshikawa T; Stercz B; Ogata M
J Neurovirol; 2017 Feb; 23(1):1-19. PubMed ID: 27538995
[TBL] [Abstract][Full Text] [Related]
4. Resource Use and Financial Impact of Oral Step-Down Therapy for Resistant Cytomegalovirus in Solid Organ Transplant Recipients.
Kleiboeker H; Descourouez JL; Schulz LT; Mandelbrot DA; Odorico JS; Saddler CM; Smith JA; Jorgenson MR
Transplant Proc; 2024 Mar; 56(2):434-439. PubMed ID: 38355369
[TBL] [Abstract][Full Text] [Related]
5. Retrospective Evaluation of Cystatin C as a Measure of Renal Function in Pediatric Hematopoietic Stem Cell Transplant Patients Receiving Foscarnet for Cytomegalovirus Reactivation.
Pickett LR; Daukshus NP; Camacho-Bydume C; Mathew S; Mauguen A; Cohen N; Cancio M
Pediatr Infect Dis J; 2024 May; 43(5):457-462. PubMed ID: 38190640
[TBL] [Abstract][Full Text] [Related]
6. A rare case of Cytomegalovirus, Scedosporium apiospermum and Mycobacterium tuberculosis in a renal transplant recipient.
Rathi M; Gundlapalli S; Ramachandran R; Mohindra S; Kaur H; Kumar V; Kohli HS; Gupta KL; Sakhuja V
BMC Infect Dis; 2014 May; 14():259. PubMed ID: 24885965
[TBL] [Abstract][Full Text] [Related]
7. Caught in the antiviral crossfire: Ganciclovir-associated mutagenesis in HSC transplant recipients.
Spencer Chapman M; Nangalia J
Cell Stem Cell; 2021 Oct; 28(10):1683-1685. PubMed ID: 34624229
[TBL] [Abstract][Full Text] [Related]
8. A case report of long-delayed diagnosis of pseudorabies virus encephalitis with endophthalmitis: lessons from metagenomic next generation sequencing.
Zhang Y; Fang L; Zhou Y; Zhang Y; Liang B; Yan C; Li L
BMC Neurol; 2023 May; 23(1):192. PubMed ID: 37194001
[TBL] [Abstract][Full Text] [Related]
9. Safety of alternative antiviral agents for neonatal herpes simplex virus encephalitis and disseminated infection.
Wang Y; Smith KP
J Pediatr Pharmacol Ther; 2014 Apr; 19(2):72-82. PubMed ID: 25024666
[TBL] [Abstract][Full Text] [Related]
10. Letter to the Editor Regarding "Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation".
Handley G; Pasikhova Y; Hill JA
Transplant Cell Ther; 2023 Oct; 29(10):645-646. PubMed ID: 37543212
[No Abstract] [Full Text] [Related]
11. CMV encephalitis in an immune-competent patient.
Micallef S; Galea R
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 29980513
[TBL] [Abstract][Full Text] [Related]
12. Viral encephalitis: a practical review on diagnostic approach and treatment.
Costa BKD; Sato DK
J Pediatr (Rio J); 2020; 96 Suppl 1(Suppl 1):12-19. PubMed ID: 31513761
[TBL] [Abstract][Full Text] [Related]
13. Varicella zoster virus encephalitis in solid organ transplant recipients: Case series and review of literature.
Kang M; Aslam S
Transpl Infect Dis; 2019 Apr; 21(2):e13038. PubMed ID: 30548548
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus encephalitis.
Arribas JR; Storch GA; Clifford DB; Tselis AC
Ann Intern Med; 1996 Oct; 125(7):577-87. PubMed ID: 8815757
[TBL] [Abstract][Full Text] [Related]
15. Standard treatment-refractory cytomegalovirus encephalitis unmasked by immune reconstitution inflammatory syndrome and successfully treated with virus-specific hyperimmune globulin.
Maximova N; Marcuzzi A; Del Rizzo I; Zanon D; Maestro A; Barbi E; Sala R
Clin Transl Immunology; 2020; 9(11):e1201. PubMed ID: 33235734
[TBL] [Abstract][Full Text] [Related]
16. Donor CMV-specific cytotoxic T lymphocytes successfully treated drug-resistant cytomegalovirus encephalitis after allogeneic hematopoietic stem cell transplantation.
Ke P; Bao X; Zhou J; Li X; Zhuang J; He X; Wu D; Zhang X; Ma X
Hematology; 2020 Dec; 25(1):43-47. PubMed ID: 31906810
[No Abstract] [Full Text] [Related]
17. Cytomegalovirus encephalitis in immunocompetent infants: A 15-year retrospective study at a single center.
Guo Y; Jiang L
Int J Infect Dis; 2019 May; 82():106-110. PubMed ID: 30844517
[TBL] [Abstract][Full Text] [Related]
18. Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy.
Hakki M
Curr Hematol Malig Rep; 2020 Apr; 15(2):90-102. PubMed ID: 31981100
[TBL] [Abstract][Full Text] [Related]
19. Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review.
El Helou G; Razonable RR
Infect Drug Resist; 2019; 12():1481-1491. PubMed ID: 31239725
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
